VCELVericel Corporation

$2B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18,000-79.8% YoY

Gross Profit

$14,00077.8% margin

Operating Income

-$29M-161333.3% margin

Net Income

-$20M-109266.7% margin

EPS (Diluted)

$-10.19

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$26M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$8M

Total Liabilities

$21M

Stockholders' Equity

-$13M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18,000	$89,000	-79.8%
Gross Profit	$14,000	$55,000	-74.5%
Operating Income	-$29M	-$18M	-63.1%
Net Income	-$20M	-$18M	-10.9%

VCEL FY 2011 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena